Search among the 179722 resources available in the repository
| dc.date.accessioned | 2025-09-30T15:00:05Z | |
| dc.date.available | 2025-09-30T15:00:05Z | |
| dc.date.issued | 2024-11-14 | |
| dc.identifier.uri | http://sedici.unlp.edu.ar/handle/10915/185275 | |
| dc.description.abstract | The main priority in leishmaniasis-endemic countries is to find safer and more accessible treatments for this neglected disease. In this study, we focus on a drug repositioning strategy using molecular docking. New molecular entities (NMEs) approved by the FDA from 2019 to the present were analyzed. The therapeutic target was the sterol 14-alpha demethylase from Leishmania infantum. Of the 125 NMEs tested, 16 demonstrated greater affinity in virtual screening than the co-crystallized inhibitor (fluconazole). This approach offers a promising method for identifying new uses for existing drugs and provides a rapid way to discover safer treatments for leishmaniasis. | en |
| dc.language | en | es |
| dc.subject | leishmaniasis | es |
| dc.subject | drug repositioning | es |
| dc.subject | molecular docking | es |
| dc.subject | Leishmania infantum | es |
| dc.subject | FDA approved drugs | es |
| dc.title | In Silico Study of FDA-Approved Drugs on Leishmania infantum CYP51, a Drug Repositioning Approach in Visceral Leishmaniasis | en |
| dc.type | Articulo | es |
| sedici.identifier.other | https://doi.org/10.3390/ecsoc-28-20201 | es |
| sedici.identifier.issn | 2673-4583 | es |
| sedici.creator.person | Guarimata, Juan Diego | es |
| sedici.creator.person | Lavecchia, Martín José | es |
| sedici.subject.materias | Química | es |
| sedici.description.fulltext | true | es |
| mods.originInfo.place | Centro de Química Inorgánica | es |
| sedici.subtype | Articulo | es |
| sedici.rights.license | Creative Commons Attribution 4.0 International (CC BY 4.0) | |
| sedici.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| sedici.relation.event | 28th International Electronic Conference on Synthetic Organic Chemistry (On line, 15-30 November 2024) | es |
| sedici.description.peerReview | peer-review | es |
| sedici.relation.journalTitle | Chemistry Proceedings | es |
| sedici.relation.journalVolumeAndIssue | vol. 16, no. 11 | es |
Except where otherwise noted, this item's license is described as Creative Commons Attribution 4.0 International (CC BY 4.0)